FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362506094> ?p ?o ?g. }

• W4362506094 endingPage "618" @default.
• W4362506094 startingPage "611" @default.
• W4362506094 abstract "Immunotherapy has improved the prognosis of many cancers, yet a large number of patients have demonstrated resistance to current immune checkpoint inhibitors. LAG-3 is an immune checkpoint expressed on tumor-infiltrating lymphocytes CD4+ and CD8+, Tregs and other immune cells. Coexpression of PD-1 and LAG-3 in solid or hematological cancers is generally associated with a poor prognosis and may be responsible for immunotherapy resistance. Dual inhibition therapy in the RELATIVITY-047 trial significantly improved progression-free survival in metastatic melanoma. This article discusses the presence of a possible synergistic interaction between LAG-3 and PD-1 in the tumor microenvironment and the utility of targeting both immune checkpoint inhibitors as an effective way to bypass resistance and increase treatment efficacy.Immunotherapy has increased survival rates for many cancer types; however, a large number of individuals experience resistance to this therapy and poor outcomes. Among the immune molecules expressed on immune cells and tumor cells, LAG-3 can favor tumor escape and progression. The coexpression of multiple immune molecules such as PD-1 and LAG-3 in multiple cancers is generally associated with a worse prognosis and might be contributing to immunotherapy failure. Dual inhibition therapy, targeting both PD-1 and LAG-3, in the RELATIVITY-047 study has shown great antitumor activity and improved survival in metastatic melanoma. This report discusses a possible synergistic interaction between LAG-3 and PD-1 within the tumor and the utility of targeting both molecules as a way to overcome resistance and improve treatment efficacy." @default.
• W4362506094 created "2023-04-05" @default.
• W4362506094 creator A5003862157 @default.
• W4362506094 creator A5005356941 @default.
• W4362506094 creator A5025842682 @default.
• W4362506094 creator A5033365467 @default.
• W4362506094 creator A5087001693 @default.
• W4362506094 date "2023-06-01" @default.
• W4362506094 modified "2023-10-18" @default.
• W4362506094 title "Simultaneous inhibition of PD-1 and LAG-3: the future of immunotherapy?" @default.
• W4362506094 cites W1992249154 @default.
• W4362506094 cites W2095876533 @default.
• W4362506094 cites W2106747061 @default.
• W4362506094 cites W2139591061 @default.
• W4362506094 cites W2160834915 @default.
• W4362506094 cites W2587048937 @default.
• W4362506094 cites W2621108701 @default.
• W4362506094 cites W2887577080 @default.
• W4362506094 cites W2898194798 @default.
• W4362506094 cites W2906369032 @default.
• W4362506094 cites W2947934006 @default.
• W4362506094 cites W2982786601 @default.
• W4362506094 cites W2987385271 @default.
• W4362506094 cites W2994950813 @default.
• W4362506094 cites W3015860015 @default.
• W4362506094 cites W3023674145 @default.
• W4362506094 cites W3043049491 @default.
• W4362506094 cites W3047297741 @default.
• W4362506094 cites W3047740167 @default.
• W4362506094 cites W3080330000 @default.
• W4362506094 cites W3083943349 @default.
• W4362506094 cites W3116788252 @default.
• W4362506094 cites W3118849389 @default.
• W4362506094 cites W3120524959 @default.
• W4362506094 cites W3128131226 @default.
• W4362506094 cites W3142890042 @default.
• W4362506094 cites W3162437281 @default.
• W4362506094 cites W3166392727 @default.
• W4362506094 cites W3168952538 @default.
• W4362506094 cites W3181707706 @default.
• W4362506094 cites W3181943450 @default.
• W4362506094 cites W3184501950 @default.
• W4362506094 cites W3200810692 @default.
• W4362506094 cites W4206494082 @default.
• W4362506094 cites W4220856235 @default.
• W4362506094 cites W4223917942 @default.
• W4362506094 cites W4224982677 @default.
• W4362506094 cites W4225394054 @default.
• W4362506094 cites W4225878231 @default.
• W4362506094 cites W4226181406 @default.
• W4362506094 cites W4280498477 @default.
• W4362506094 cites W4283693131 @default.
• W4362506094 cites W4283708528 @default.
• W4362506094 cites W4286295255 @default.
• W4362506094 cites W4288041492 @default.
• W4362506094 cites W4292229910 @default.
• W4362506094 cites W4294152300 @default.
• W4362506094 cites W4294204141 @default.
• W4362506094 cites W4297294278 @default.
• W4362506094 cites W4308485699 @default.
• W4362506094 cites W4310103279 @default.
• W4362506094 doi "https://doi.org/10.2217/imt-2022-0185" @default.
• W4362506094 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37009648" @default.
• W4362506094 hasPublicationYear "2023" @default.
• W4362506094 type Work @default.
• W4362506094 citedByCount "2" @default.
• W4362506094 countsByYear W43625060942023 @default.
• W4362506094 crossrefType "journal-article" @default.
• W4362506094 hasAuthorship W4362506094A5003862157 @default.
• W4362506094 hasAuthorship W4362506094A5005356941 @default.
• W4362506094 hasAuthorship W4362506094A5025842682 @default.
• W4362506094 hasAuthorship W4362506094A5033365467 @default.
• W4362506094 hasAuthorship W4362506094A5087001693 @default.
• W4362506094 hasConcept C121608353 @default.
• W4362506094 hasConcept C126322002 @default.
• W4362506094 hasConcept C143998085 @default.
• W4362506094 hasConcept C203014093 @default.
• W4362506094 hasConcept C2776107976 @default.
• W4362506094 hasConcept C2777658100 @default.
• W4362506094 hasConcept C2777701055 @default.
• W4362506094 hasConcept C2780674031 @default.
• W4362506094 hasConcept C2780851360 @default.
• W4362506094 hasConcept C2781053074 @default.
• W4362506094 hasConcept C502942594 @default.
• W4362506094 hasConcept C71924100 @default.
• W4362506094 hasConcept C8891405 @default.
• W4362506094 hasConceptScore W4362506094C121608353 @default.
• W4362506094 hasConceptScore W4362506094C126322002 @default.
• W4362506094 hasConceptScore W4362506094C143998085 @default.
• W4362506094 hasConceptScore W4362506094C203014093 @default.
• W4362506094 hasConceptScore W4362506094C2776107976 @default.
• W4362506094 hasConceptScore W4362506094C2777658100 @default.
• W4362506094 hasConceptScore W4362506094C2777701055 @default.
• W4362506094 hasConceptScore W4362506094C2780674031 @default.
• W4362506094 hasConceptScore W4362506094C2780851360 @default.
• W4362506094 hasConceptScore W4362506094C2781053074 @default.
• W4362506094 hasConceptScore W4362506094C502942594 @default.
• W4362506094 hasConceptScore W4362506094C71924100 @default.

• next